These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Tenecteplase versus alteplase for acute ischemic stroke. González RG N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969 [No Abstract] [Full Text] [Related]
11. Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused. Davis SM; Hand PJ; Donnan GA Med J Aust; 2007 Nov; 187(10):548-9. PubMed ID: 18021039 [TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little. Hoffman JR Med J Aust; 2003 Oct; 179(7):333-4. PubMed ID: 14503891 [No Abstract] [Full Text] [Related]
13. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses". Liao X; Wang Y; Wang Y Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031 [No Abstract] [Full Text] [Related]
14. Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion". Coutts SB; Hill MD Stroke; 2015 Jun; 46(6):e150. PubMed ID: 25899240 [No Abstract] [Full Text] [Related]
15. MRI-assisted thrombolysis for delayed arrival among patients with ischemic stroke. Khatri R; Miley JT; Qureshi AI J Neuroimaging; 2011 Oct; 21(4):307-8. PubMed ID: 21121999 [No Abstract] [Full Text] [Related]
16. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses". Chao AC; Po HL; Chan L Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029 [No Abstract] [Full Text] [Related]
17. Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion". Behrouz R; Mutgi SA; Silver B Stroke; 2015 Jun; 46(6):e149. PubMed ID: 25899241 [No Abstract] [Full Text] [Related]
18. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Bruno A; Switzer JA Neurology; 2012 Jul; 79(5):486-7; author reply 486-7. PubMed ID: 22851721 [No Abstract] [Full Text] [Related]
19. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Kent TA Neurology; 2012 Apr; 78(17):1368. PubMed ID: 22529207 [No Abstract] [Full Text] [Related]
20. Questions about authorisation of alteplase for ischaemic stroke. Shinton R Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265 [No Abstract] [Full Text] [Related] [Next] [New Search]